Teva tackles migraine through potential $400m Heptares collaboration
Jennifer Morrison featured in Teva migraine awareness campaign. - Philadelphia Business Journal
FDA approves Vyepti, first IV preventive treatment for migraine
Ajovy Now Available in Autoinjector Device for Migraine Prevention - MPR
Teva Canada Announces Product Availability of AJOVY™ | Business Wire
Teva launches AJOVY for the treatment of migraine with the YpsoMate autoinjector from Ypsomed - Ypsomed - Group
Ajovy, Teva's migraine drug, recommended by UK's NICE.
Teva's recalled migraine medicine Zecuity has a long local history - Philadelphia Business Journal
Beyond Migraine
Teva Wins Three, Loses Six in Patent Battle Over Migraine Drug – PharmaLive
Teva's migraine med given marketing authorization
Teva Pharmaceuticals on Twitter: "Meet our #migraine expert, Dr Joshua Cohen, as he shares his own story of living with #migraine and explains the impact the disease can have on patients. Read
Teva to Present Latest Data on AJOVY® (fremanezumab-vfrm) Injection at the 2022 American Headache Society Annual Meeting
Teva Halts Phase III Trial of Fremanezumab in Chronic Cluster Headaches
Xconomy: Teva Migraine Drug Likely Delayed by Manufacturing Trouble
Teva tries to make something out of nothing with Ajovy approval | Evaluate
Fed Circ. upholds some Teva migraine drug patents, invalidates others | Reuters
Teva migraine medicine gets EU positive opinion
Teva discontinues trial of Ajovy for episodic cluster headache - Pharmaceutical Technology
Teva Shares Pop as FDA Approves Its Migraine Drug - TheStreet
Eli Lilly avoids sanctions in Teva migraine treatment dispute
Preventive Treatment of Migraine–AJOVY® (fremanezumab-vfrm) injection
No joy for Ajovy: Teva's migraine drug can't find a convincing win in meta-analysis versus Biohaven, AbbVie meds | Fierce Pharma
Teva notched a win in its migraine patent feud with Eli Lilly
